Lei Deng

Assistant Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lei Deng is an Assistant Professor at the University of Washington and the Fred Hutchinson Cancer Center in the United States. His research focuses on cancer outcomes, with recent articles examining survival in lung adenocarcinoma, KRAS mutations in non-small cell lung cancer, and factors influencing treatment disparities. He also investigates the impact of psychological distress and transportation barriers on cancer survivors’ health care access.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Chen Hu

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Micah Tratt

Fred Hutch Cancer Center

UNITED STATES

View details

Changchuan Jiang

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lei Deng

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy

Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of Prostate Cancer

Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885

Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer

Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non–Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance

Transportation barriers, emergency room use, and mortality risk among US adults by cancer history

Medicaid expansion and racial disparity in timely multidisciplinary treatment in muscle invasive bladder cancer

Self-reported Transportation Barriers to Health Care Among US Cancer Survivors.

Prevalence of Underlying Medical Conditions Associated With Severe COVID-19 Illness in Adult Cancer Survivors in the United States.

Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma.

Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018.

Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy.

Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.

Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review.

Collaborators (3)

Chen Hu

Micah Tratt

Changchuan Jiang

Make your next move.